Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1627-1638

  Ahn, Yong Tae ^a   Chua, Mei Sze ^a   Whitlock, James P ^a   Shin, Yong Chil ^b   Song, Woon Heung ^b   Kim, Yongkuk ^c   Eom, Chi Yong ^d   An, Won Gun ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shinhan University   (South Korea)

^c Kyungpook National University   (South Korea)

^d Korea Basic Science Institute (KBSI)   (South Korea)

^e Pusan National University   (South Korea)

Author keywords

Enhancer; Hepa1c1c7 cells; Hypoxia; Hypoxia inducible factor 1; Hypoxia inducible factor 2; Hypoxia response element; Plasminogen activator inhibitor 1; Protein DNA interaction; Transcription

Indexed keywords

DEOXYRIBONUCLEASE I; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; GENE ACTIVITY; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; RESPONSE ELEMENTS; RODENTIA; SERPIN E2; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 78649964350     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000817     Document Type: Article

References (44)

1. Gordan JD and Simon MC: Hypoxia-inducible factors: Central regulators of the tumor phenotype. Curr Opin Genet Dev 17: 71-77, 2007.
2. Gu YZ, Hogenesch JB and Bradfield CA: The PAS superfamily: Sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40: 519-561, 2000.
3. Crews ST and Fan CM: Remembrance of things PAS: Regulation of development by bHLH-PAS proteins. Curr Opin Genet Dev 9: 580-587, 1999.
4. Semenza GL: Expression of hypoxia-inducible factor 1: Mechanisms and consequences. Biochem Pharmacol 59: 47-53, 2000.
5. Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480, 2006.
6. Semenza GL: HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480, 2000.
7. Pinsky DJ, Liao H, Lawson CA, et al: Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102: 919-928, 1998. (Pubitemid 28419237)
8. Kietzmann T, Roth U and Jungermann K: Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94: 4177-4185, 1999.
9. Fink T, Kazlauskas A, Poellinger L, Ebbesen P and Zachar V: Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99: 2077-2083, 2002.
10. Samoylenko A, Roth U, Jungermann K and Kietzmann T: The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. Blood 97: 2657-2666, 2001.
11. Gorlach A, Diebold I, Schini-Kerth VB, et al: Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 89: 47-54, 2001.
12. Dietzmann K, von Bossanyi P, Krause D, Wittig H, Mawrin C and Kirches E: Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the cns and brain injuries following dramatic circulatory arrests: An immunohistochemical study. Pathol Res Pract 196: 15-21, 2000. (Pubitemid 30046522)
13. Agirbasli M: Pivotal role of plasminogen-activator inhibitor 1 in vascular disease. Int J Clin Pract 59: 102-106, 2005.
14. Frandsen TL, Holst-Hansen C, Nielsen BS, et al: Direct evidence of the importance of stromal urokinase plasminogen activator (UPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res 61: 532-537, 2001.
15. Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K and Johnsen M: Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice. Oncogene 22: 4389-4397, 2003.
16. Bajou K, Masson V, Gerard RD, et al: The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152: 777-784, 2001.
17. Kwaan HC, Wang J, Svoboda K and Declerck PJ: Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br J Cancer 82: 1702-1708, 2000.
18. Prendergast GC, Diamond LE, Dahl D and Cole MD: The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10: 1265-1269, 1990.
19. Kunz C, Pebler S, Otte J and von der Ahe D: Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23: 3710-3717, 1995.
20. Pappot H, Pedersen AN, Brunner N and Christensen IJ: The complex between urokinase (uPA) and its type-1 inhibitor (PAI-1) in pulmonary adenocarcinoma: Relation to prognosis. Lung Cancer 51: 193-200, 2006.
21. Sternlicht MD, Dunning AM, Moore DH, et al: Prognostic value of PAI1 in invasive breast cancer: Evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Cancer Epidemiol Biomarkers Prev 15: 2107-2114, 2006.
22. Osmak M, Niksic D, Brozovic A, Ristov AA, Vrhovec I and Skrk J: Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis. Anticancer Res 19: 3193-3197, 1999.
23. Okino ST, Chichester CH and Whitlock JP Jr: Hypoxia-inducible mammalian gene expression analyzed in vivo at a tata-driven promoter and at an initiator-driven promoter. J Biol Chem 273: 23837-23843, 1998.
24. Okino ST and Whitlock JP Jr: Cytochrome p450 gene regulation. Analysis of protein-DNA interactions in situ. Methods Mol Biol 107: 395-404, 1998.
25. Salceda S, Beck I and Caro J: Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys 334: 389-394, 1996.
26. Dachs GU and Tozer GM: Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 36: 1649-1660, 2000.
27. Ding H, Benotmane AM, Suske G, Collen D and Belayew A: Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene. J Biol Chem 274: 19573-19580, 1999.
28. Kvietikova I, Wenger RH, Marti HH and Gassmann M: The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 23: 4542-4550, 1995.
29. Hopkins WE, Westerhausen DR, Fujii S, Billadello JJ and Sobel BE: Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets. Thromb Haemost 66: 239-245, 1991.
30. Kimura D, Imaizumi T, Tamo W, et al: Hypoxia enhances the expression of plasminogen activator inhibitor-1 in human lung cancer cells, EBC-1. Tohoku J Exp Med 196: 259-267, 2002.
31. Liao H, Hyman MC, Lawrence DA and Pinsky DJ: Molecular regulation of the PAI-1 gene by hypoxia: Contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 21: 935-949, 2007.
32. Kuo MH and Allis CD: In vivo cross-linking and immunoprecipitation for studying dynamic protein:DNA associations in a chromatin environment. Methods 19: 425-433, 1999.
33. Mueller PR and Wold B: In vivo footprinting of a muscle-specific enhancer by ligation mediated PCR. Science 246: 780-786, 1989.
34. Wojta J, Kaun C, Breuss JM, et al: Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest 79: 427-438, 1999.
35. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
36. Yu F, White SB, Zhao Q and Lee FS: HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98: 9630-9635, 2001.
37. Kasper LH and Brindle PK: Mammalian gene expression program resiliency: The roles of multiple coactivator mechanisms in hypoxia-responsive transcription. Cell Cycle 5: 142-146, 2006.
38. Carroll VA and Ashcroft M: Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res 66: 6264-6270, 2006.
39. Sato M, Tanaka T, Maemura K, et al: The PAI-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells. Am J Respir Cell Mol Biol 31: 209-215, 2004.
40. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
41. Chen J, Zhao S, Nakada K, et al: Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 162: 1283-1291, 2003.
42. Rapisarda A, Uranchimeg B, Scudiero DA, et al: Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 62: 4316-4324, 2002.
43. Kung AL, Zabludoff SD, France DS, et al: Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6: 33-43, 2004.
44. Kong D, Park EJ, Stephen AG, et al: Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 65: 9047-9055, 2005.